Primary Job Title CSO Primary Organization 
TRImaran Pharma
Location Cambridge, Massachusetts, United States Regions Greater Boston Area, East Coast, New England Gender Male
LinkedIn View on LinkedIn
Frank Bymaster was a distinguished pre-clinical scientist with over 30 years of experience within the Neuroscience Division at Lilly. He played a critical role in the discovery and development of the commercialized Lilly antidepressants Prozac, Cymbalta and Symbyax. In addition he was a key player in the success of the blockbuster antipsychotic
Zyprexa and the ADHD compound Strattera.
He is author of more than 120 scientific publications, book chapters, etc., and is an inventor on more than 20 US patents.
Bymaster holds a B.S. cum laude in Pharmacy from Butler University and an M.S. in Pharmacology from Indiana University, Bloomington.
